An Italian Multicenter Retrospective Observational Study to Assess Effectiveness and Safety of Siltuximab for Patients with Castleman's Disease Treated in Italy in a Real-life Context
Clinical trial NCT06720870 · RECRUITING
Trial details
- NCT number
- NCT06720870
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-01-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.